HRA Pharma says that nearly a third of adult women in the US who have tried to obtain a prescription for birth control or a refill have reported difficulties doing so.

Perrigo (NYSE:PRGO) said has received an offer to sell its HRA Pharma rare diseases unit to Esteve Healthcare for a total consideration of up to €275 million.The consideration includes an ...

And drove sales of ellaOne to an all-time high. A pharmaceutical company that drives a public discussion and even invests into a sexual empowerment campaign is unseen not only in ...